Skip to content

Study on the dose-response relationship between the number of acupoints and immediate analgesia in primary dysmenorrhea

Study on the dose-response relationship between the number of acupoints and immediate analgesia in primary dysmenorrhea

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080923
Enrollment
Unknown
Registered
2024-02-18
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Dysmenorrhea

Interventions

1 needle group:Acupuncture at unilateral Sanyinjiao (SP6) with filiform needle
2 needles group:Acupuncture at bilateral Sanyinjiao (SP6) with filiform needle
3 needles group:Acupuncture at bilateral Sanyinjiao (SP6) and unilateral Ciliao (BL32) with filiform needle
4 needles group:Acupuncture at bilateral Sanyinjiao (SP6), Ciliao (BL32) with filiform needle
5 needles group:Acupuncture at bilateral Sanyinjiao (SP6), bilateral Ciliao (BL32), and unilateral Diji (SP8) with filiform needle
6 needles group:Acupuncture at bilateral Sanyinjiao (SP6), bilateral Ciliao (BL32), and bilateral Diji (SP8) with filiform needle

Sponsors

Jinan City Changqing District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 35 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of primary dysmenorrhea. (2) Age 16-35 years old. (3) The menstrual cycle is regular (28 ± 7 days). (4) The average score of the Visual Analogue Scale (VAS) of dysmenorrhea for 3 consecutive menstrual cycles was =4. (5) Those who did not take analgesics, sedatives, hormonal drugs or other forms of treatment within 2 weeks before enrollment. (6) Sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with secondary dysmenorrhea caused by pelvic inflammatory disease, endometriosis, adenomyosis or other factors confirmed by B-ultrasound and gynecological examination. (2) Pregnant or lactating women. (3) Patients with serious life-threatening primary diseases, such as cardiovascular and cerebrovascular disease, liver disease, kidney disease, hematopoietic system disease and mental illness. (4) Patients with irregular menstrual cycles and intermittent episodes of dysmenorrhea.

Design outcomes

Primary

MeasureTime frame
Reduced VAS scores compared to before treatment;

Secondary

MeasureTime frame
Pain VAS score at 5min of acupuncture;Pain VAS score at 10min of acupuncture;Pain VAS score at 20min of acupuncture;Pain VAS score at 30min after acupuncture;Pain VAS score at 60min after acupuncture;Pain VAS score at 120min after acupuncture;Scoring of the COX Dysmenorrhea Symptom Scale;SF-MPQ;

Countries

China

Contacts

Public ContactMou Zijun; Wang Bin

Shandong University of Traditional Chinese Medicine; Jinan City Changqing District People's Hospital

mouzijun@163.com+86 188 1314 7960

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026